¡Ya estamos en !
Descubre más
LHDX
Lucira Health, Inc. Common Stock
Excluida de cotización
LHDX dejó de cotizar en bolsa el 3 de marzo de 2023.
Acerca de: Lucira Health Inc is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. It has developed a testing platform that produces high-complexity-laboratory-accurate molecular testing in a single-use and user-friendly test kit that is powered by two AA batteries and fit in the palm of a hand. The company's initial focus is within respiratory diseases, and initially for COVID-19 and influenza Types A and B indications.
Empleados: 221
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
No hemos recibido artículos de noticias recientes sobre LHDX.
Gráficos de precios implementados con Lightweight Charts™